The expression of LC3 is elevated in the lungs of patients with pulmonary hypertension, and the conversion rate of LC3-I to LC3-II is also significantly increased, especially in the endothelial cell layer and the outer and middle layers of the resistance vessels. Here, MAP1LC3A is linked to pulmonary hypertension.